Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MORPHOSYS AG

(MOR)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 08/05 01:11:17 pm
46.415 EUR   +3.24%
11:08aEuropean ADRs Move Higher in Thursday Trading
MT
08/04European ADRs Move Slightly Higher in Wednesday Trading
MT
08/04MORPHOSYS : JP Morgan gives a Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société MORPHOSYS AG
08/03MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
08/02MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
08/02MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
08/02MORPHOSYS : Notification of managers`transactions according to article 19 MAR (F..
PU
08/02CORRECTION OF A RELEASE FROM 30/07/2 : 30 CET/CEST - MorphoSys AG: Release accor..
PU
07/30MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
07/30MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
PU
07/30MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
EQ
07/29MORPHOSYS : Reports Second Quarter and First Half 2021 Results (Form 6-K)
PU
07/28MORPHOSYS : Reports Second Quarter and First Half 2021 Results
PU
07/28MORPHOSYS : Reports Second Quarter and First Half 2021 Results
EQ
07/26AD HOC : MorphoSys AG to update financial guidance for 2021 and reduce financial..
PU
07/26AD-HOC : MorphoSys AG to update financial guidance for 2021 and reduce financial..
PU
07/21MORPHOSYS : Invitation to MorphoSys' Second Quarter and First Half 2021 Results ..
PU
07/21MORPHOSYS : Invitation to MorphoSys' Second Quarter and First Half 2021 Results ..
PU
07/21MORPHOSYS : Invitation to MorphoSys' Second Quarter and First Half 2021 Results ..
EQ
07/21MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
07/19MorphoSys Concludes a US$ 100 Million Capital Increase to Implement the Purch..
AQ
07/16MorphoSys AG
AQ
07/16MORPHOSYS : Concludes a US$ 100 Million Capital Increase to Implement the Purcha..
PU
07/16MORPHOSYS : Concludes a US$ 100 Million Capital Increase to Implement the Purcha..
PU
07/16MORPHOSYS : Concludes a US$ 100 Million Capital Increase to Implement the Purcha..
EQ
07/15MORPHOSYS : to Complete Transformational Acquisition of Constellation Pharmaceut..
PU
07/15MORPHOSYS : to Complete Transformational Acquisition of Constellation Pharmaceut..
PU
07/15MORPHOSYS : to Complete Transformational Acquisition of Constellation Pharmaceut..
EQ
07/01MORPHOSYS : Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acq..
PU
07/01MORPHOSYS : Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acq..
PU
07/01MORPHOSYS : Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acq..
EQ
06/30MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
PU
06/30MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
EQ
06/25MORPHOSYS : and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combina..
PU
06/25MORPHOSYS : and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combina..
EQ
06/25INCYTE : and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combina..
BU
06/25MORPHOSYS : and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combina..
PU
06/24MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
06/24MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
06/17MORPHOSYS : Commences Cash Tender Offer for All Outstanding Shares of Constellat..
PU
06/16MORPHOSYS : Commences Cash Tender Offer for All Outstanding Shares of Constellat..
PU
06/16MORPHOSYS : Commences Cash Tender Offer for All Outstanding Shares of Constellat..
EQ
06/07MORPHOSYS : Notification of managers`transactions according to article 19 MAR (F..
PU
06/07MORPHOSYS AG : Notification and public disclosure of transactions by persons
EQ
06/07MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
06/07MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
06/07INCYTE : MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND St..
AQ
06/04MORPHOSYS : and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of ..
PU
06/04MORPHOSYS : and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of ..
PU
06/04MORPHOSYS : and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of ..
EQ
06/02CONSTELLATION PHARMACEUTICALS : German biotech company MorphoSys buys US rival f..
AQ
06/02MORPHOSYS : to Acquire Constellation Pharmaceuticals and Enter into Strategic Fu..
PU
06/02MORPHOSYS : to Acquire Constellation Pharmaceuticals
EQ
06/02MORPHOSYS : to Acquire Constellation Pharmaceuticals and Enter into Strategic Fu..
EQ
05/24MORPHOSYS : To Participate in UBS Global Healthcare Conference
AQ
05/21MORPHOSYS : To Participate in UBS Global Healthcare Conference (Form 6-K)
PU
05/21MORPHOSYS : To Participate in UBS Global Healthcare Conference
PU
05/21MORPHOSYS : To Participate in UBS Global Healthcare Conference
EQ
05/20MORPHOSYS : Voting results of MorphoSys Annual General Meeting 2021 (Form 6-K)
PU
05/20MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
05/20MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
05/20MORPHOSYS : to Present Data on Tafasitamab (Monjuvi) at the 2021 ASCO Annual Mee..
AQ
05/20MORPHOSYS : to Present Data on Tafasitamab (Monjuvi®) at the 2021 ASCO Annual Me..
PU
05/19MORPHOSYS : to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual ..
PU
05/19MORPHOSYS : to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual ..
EQ
05/18MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
05/17MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
05/14MORPHOSYS : and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study E..
PU
05/14MORPHOSYS AG : Release according to Article 41 of the WpHG [the German Securitie..
EQ
05/11MORPHOSYS : and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study E..
PU
05/11INCYTE : and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study E..
BU
05/11MORPHOSYS : and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study E..
EQ
05/07MORPHOSYS : 1st Quarter Interim Statement 2021*
PU
05/06MORPHOSYS : First Quarter Interim Statement January - March 2021
PU
05/05MORPHOSYS : Reports First Quarter 2021 Results
PU
05/05MORPHOSYS : Reports First Quarter 2021 Results
EQ
05/04MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
04/29MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MORPHOSYS AG
08/31/21